Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Achieve Life Sciences, Inc. is a late-stage clinical specialty pharmaceutical company dedicated to combating nicotine dependence through its product candidate, cytisinicline. Targeting the 29 million U.S. smokers and 11 million e-cigarette users, Achieve aims to address a significant health crisis. With FDA Breakthrough Therapy Designation, cytisinicline is positioned to become the first new prescription treatment for smoking cessation in nearly two decades, offering a promising solution with a favorable safety profile.
This description was generated via AI from an annual report. Updated about 1 year ago.